ABSTRACT SUBMISSION GUIDELINES

Abstract Submission Opens: Wednesday 15 October 2025

Deadline: 11:59pm, Sunday 14 December 2025

The main theme for ASID ASM 2025 is, ‘Exploring the Terrain: Humans, Vectors and Pathogens” highlighting our deepening relationship with the natural environment, its ecosystems, and the evolving pathways of disease transmission.

For your presentation to being considered, these abstract guidelines must be followed. Please ensure that the presenting author completes the abstract submission. Abstracts must be submitted by 11:59pm, Sunday 14 December, Australian, Daylight Savings Time.

PRESENTATION TYPE

Presentation type	Time allocation	Explanation
Research-based oral presentation	12 minute presentation + Q&A	Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge
Practice-based oral presentation	12 minute presentation + Q&A	Oral presentations analysing issues and solutions to problems in clinical practice, community engagement, education, health promotion and policy. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge and practice.
Case study oral presentation	12minute presentation + Q&A	Oral presentations on case studies describe the management of a patient emphasising the unusual clinical features that distinguished it from typical cases. It outlines the diagnostic and therapeutic decision-making process, including key challenges encountered. The case offers practical insights and lessons relevant to clinicians managing similar presentations.
Poster Presentation	Permanently displayed during the Conference	Posters will be displayed within the exhibition and catering area. A number of top ranked posters in each theme will be allocated to a poster tour.

CONFERENCE THEMES FOR PRESENTATIONS

Name	Explanation / overview
Clinical ID	Abstracts will present research that seeks to improve the prevention, diagnosis, and treatment of infectious diseases in Australia and the Pacific region.
Social science and policy	Abstracts may include empirical or non-empirical (conceptual/theoretical) studies which focus on social, structural, cultural, material and policy contexts affecting infectious diseases in Australia and the Pacific region.
Antimicrobial stewardship	Abstracts will present research that seeks to improve antimicrobial stewardship practice in Australia and the Pacific region.
Infection prevention and Control	Abstracts will present research that seeks to improve IPC practices in Australia and the Pacific region.
One Health i.e. Epidemiology, Public Health and One Health	Abstracts will present research on the social, cultural, environmental, occupational, and economic factors affecting infectious diseases in Australia and the Pacific region.

KEYWORDS

The following keywords are used to assist with appropriate allocation of reviewers. Please select at least three from the following list:

Aboriginal and Torres Strait Islander Health
Antimicrobial resistance
Antimicrobial stewardship
Artificial intelligence
Bacteriology
Clinical microbiology
Community development
Diagnostics
Drug development
Education and health promotion
Epidemiology
Immunocompromised host
Infection prevention and control
Infectious diseases health policy
Modelling
Mycology
One Health
Paediatrics
Parasitology
Priority populations
Public health
Surveillance
Therapeutics
Vaccination
Virology

ALL ABSTRACTS MUST INCLUDE:

Disclosure of Interest Statement:

Example: “The Australasian Society for Infectious Diseases recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in

publications and presentations.”

Disclosure of interest statement – Industry:

Example 1. Organisation X declares payments to his institution for investigator-initiated research from Industry Company X.

Example 2. Organisation X has received donated materials from Industry Company X. All other authors declare no competing interests.

Acknowledgement of Funding

Example 1. This study was funded in part by the Government Body X.

Example 2. Organisation X receive grant funding from the Government Body X. No pharmaceutical / Industry grants were received for this study.

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

ABSTRACT SUBMISSION PROCESS

Abstracts must be submitted electronically through the online abstract submission site. You will be required to enter:

Preferred theme
Preferred presentation type: Oral Presentation, Poster Presentation and Oral or Poster Presentation
Authors’ names (indicate presenting author and contact details - address, telephone and email). Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible. If scholarships are available, preference will be given to those who do submit abstracts, however authors should ensure they are able to fund their own travel if need be
Authors’ affiliations
Abstract title
Abstract as a word document (maximum 250 words) plus a disclosure of interest statement
Short biography of presenter (maximum 50 words). This information will be used by the session chair for introductory purposes and may be published in conference literature
Keywords
Indicate if the presenter of this abstract a:

Trainee
PhD Student
Early career researcher
ASID member

CONFERENCE REGISTRATION

Abstract presenting authors will be required to fund their own attendance at the conference.

All presenting authors will be required to register for the conference. Any presenter not registered will be removed from the program.